World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
48672
World Ranking
14818
National Ranking
37

Itamar Raz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Itamar Raz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 497 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Itamar Raz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Itamar Raz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Itamar Raz is affiliated with the Hebrew University of Jerusalem in Israel and has contributed extensively to the field of medical research, particularly focusing on endocrinology, diabetes, and metabolism. Their body of work spans a wide range of topics within medicine, with a principal emphasis on diabetes treatment and management.

Their research covers several interconnected areas, including:

  • Diabetes Treatment and Management
  • Metabolism, Diabetes, and Cancer
  • Pancreatic function and diabetes
  • Diabetes Management and Research
  • Diabetes and associated disorders
  • Chronic Kidney Disease and Diabetes
  • Diabetes, Cardiovascular Risks, and Lipoproteins

Itamar Raz has co-authored numerous publications with several frequent collaborators. These include:

  • Marc S. Sabatine
  • Ofri Mosenzon
  • Deepak L. Bhatt
  • Lawrence A. Leiter
  • Avivit Cahn

The scientist's work appears consistently in reputable journals, indicating a focus on cardiovascular and diabetes-related research. Their most frequent publication venues are:

  • Circulation
  • Journal of the American College of Cardiology
  • Diabetes Research and Clinical Practice
  • Diabetes Care
  • Diabetes/Metabolism Research and Reviews

Their research spans the broader field of Medicine, with notable emphasis on specific subfields such as:

  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Surgery
  • Cardiology and Cardiovascular Medicine
  • Nephrology

Among the recent scientific publications associated with Itamar Raz are:

  • Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus, 2020, Circulation
  • Adolescent Obesity and Early-Onset Type 2 Diabetes, 2020, Diabetes Care
  • Overview of oxidative stress and inflammation in diabetes, 2024, Journal of Diabetes
  • A meta-analysis of GFR slope as a surrogate endpoint for kidney failure, 2023, Nature Medicine
  • Prediction of progression from pre-diabetes to diabetes: Development and validation of a machine learning model, 2020, Diabetes/Metabolism Research and Reviews

Best Publications

  • Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

    Edmond J Lewis;Lawrence G Hunsicker;William R Clarke;Tomas Berl

  • Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

    Benjamin M. Scirica;Deepak L. Bhatt;Deepak L. Bhatt;Eugene Braunwald;P. Gabriel Steg

  • SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

    Thomas A Zelniker;Stephen D Wiviott;Itamar Raz;Kyungah Im

  • Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

    Lars Rydén;Eberhard Standl;Małgorzata Bartnik;Greet Van den Berghe

  • Type 2 diabetes mellitus.

    Ralph A. DeFronzo;Ele Ferrannini;Leif Groop;Robert R. Henry

  • Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ

    F. Zurlo;S. Lillioja;A. Esposito del Puente;B. L. Nyomba

  • Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy The SYDNEY 2 trial

    Dan Ziegler;Alexander Ametov;Alexey Barinov;Peter J. Dyck

  • Heart Failure, Saxagliptin and Diabetes Mellitus: Observations from the SAVOR - TIMI 53 Randomized Trial

    Benjamin M. Scirica;Eugene Braunwald;Itamar Raz;Matthew A. Cavender

  • β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

    Itamar Raz;Dana Elias;Ann Avron;Merana Tamir

  • Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus.

    Thomas A. Zelniker;Stephen D. Wiviott;Itamar Raz;KyungAh Im

  • Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.

    Ofri Mosenzon;Stephen D Wiviott;Avivit Cahn;Aliza Rozenberg

  • Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.

    Eri T. Kato;Michael G. Silverman;Ofri Mosenzon;Thomas A. Zelniker

  • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy

    Tomas Berl;Lawrence G. Hunsicker;Julia B. Lewis;Marc A. Pfeffer

  • Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.

    Itamar Raz;Peter W.F. Wilson;Krzysztof Strojek;Irina Kowalska

  • Impact of Achieved Blood Pressure on Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial

    Tomas Berl;Lawrence G. Hunsicker;Julia B. Lewis;Marc A. Pfeffer

  • Insulin resistance associated with lower rates of weight gain in Pima Indians

    Boyd A Swinburn;Bulangu L Nyomba;Mohammad F Saad;Francesco Zurlo

  • Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors’ Expert Forum

    William T. Cefalu;Sanjay Kaul;Hertzel C. Gerstein;Rury R. Holman

  • Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.

    Thomas A. Zelniker;Thomas A. Zelniker;Marc P. Bonaca;Marc P. Bonaca;Remo H.M. Furtado;Remo H.M. Furtado;Ofri Mosenzon

  • Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus.

    Allison S. Kennington;Cynthia R. Hill;James Craig;Clifton Bogardus

  • Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.

    Remo H.M. Furtado;Remo H.M. Furtado;Marc P. Bonaca;Itamar Raz;Thomas A. Zelniker

Frequent Co-Authors

Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Darren K. McGuire
Darren K. McGuire The University of Texas Southwestern Medical Center
Stephen D. Wiviott
Stephen D. Wiviott Brigham and Women's Hospital
John P.H. Wilding
John P.H. Wilding University of Liverpool
Eugene Braunwald
Eugene Braunwald Harvard Medical School
Lawrence A. Leiter
Lawrence A. Leiter University of Toronto
Sabina A. Murphy
Sabina A. Murphy Brigham and Women's Hospital
Stefano Del Prato
Stefano Del Prato University of Pisa
Allan Flyvbjerg
Allan Flyvbjerg Steno Diabetes Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but aren’t sure about pursuing a full MD, there are several rewarding healthcare career pathways available online. Many students start by exploring the best online schools for high school students who wish to gain early exposure to health sciences before committing to further study.

For those looking to enter the workforce quickly, an increasingly popular route is earning a medical coding certification online. This program prepares students for administrative roles in clinics, hospitals, or insurance companies with the flexibility of remote learning.

Nursing remains one of the most sought-after professions, and affordable online pathways are now widely available. Prospective advanced practice nurses can consider cheap online fnp programs, enabling them to become Family Nurse Practitioners and provide primary care across communities.

For those at the beginning of their nursing journey, there are comprehensive online nursing programs that offer flexible study options for aspiring RNs and LPNs. These diverse degree and certification options provide practical, affordable pathways into the healthcare field beyond traditional medical school.

Best Scientists Citing Itamar Raz

Trending Scientists

Recently Published Articles